Key result
Baseline vascular risk factor burden was associated with higher depressive symptoms over 8 years (total effect 0.014; 95% CI 0.007-0.021), with C-reactive protein mediating 20.1% of this effect.
Why the study?
It was unknown whether low-grade systemic inflammation mediates the association between vascular risk factors and depressive symptoms.
Does cumulative vascular risk factor burden increase depressive symptoms in adults, and is this mediated by C-reactive protein?
Cohort (n=9,034)
Does cumulative vascular risk factor burden increase depressive symptoms in adults, and is this mediated by C-reactive protein?
Effect estimate: total effect 0.014 (95% CI 0.007-0.021)
The association between vascular risk factor burden and depressive symptoms is partially mediated by systemic inflammation (CRP), specifically promoting symptoms of tiredness and appetite changes.
Suggests CRP partly mediates vascular-depression link; hypothesis-generating and should not yet change practice.
People with vascular risk factors (VRFs) are at higher risk for depressive symptoms. Given recent findings implicating low-grade systemic inflammation in both vascular and mental health, this study examined the extent to which the VRF–depressive symptom association might be mediated by low-grade systemic inflammation. To this end, we analysed longitudinal data of 9,034 participants from the UK Biobank (mean age = 56.54 years), who took part in three consecutive assessments over the course of about 8 years. Cumulative VRF burden at baseline was defined as the presence of 5 VRFs (hypertension, obesity, hypercholesterolemia, diabetes, and smoking). Low-grade systemic inflammation was assessed using serum-derived C-reactive protein (CRP) and depressive symptoms were measured using the Patient Health Questionnaire-9 (PHQ-9). We performed mediation models using longitudinal data and a path analytic framework, while controlling for age, gender, racial-ethnic background, socioeconomic status, and baseline mood. VRFs at baseline showed a small association with higher depressive symptoms at follow-up (total effect = 0.014, 95% CI [0.007; 0.021]). CRP mediated this association (indirect effect = 0.003, 95% CI [0.001; 0.005]) and accounted for 20.10% of the total effect of VRF burden on depressive symptoms. Exploratory analyses taking a symptom-based approach revealed that mediating pathways pertained to specific depressive symptoms: tiredness and changes in appetite. These results suggest that the small association between VRF burden and depressive symptoms may be partly explained by the inflammation-promoting effects of VRFs, which might promote a specific symptom-profile of depression.
No takes yet. Share an insight, caveat, or question.
Romankiewicz et al. (2022) conducted a cohort in Depressive symptoms (n=9,034). Vascular risk factors (VRFs) was evaluated on Depressive symptoms measured using the Patient Health Questionnaire-9 (PHQ-9) (total effect 0.014, 95% CI 0.007-0.021). Baseline vascular risk factor burden was associated with higher depressive symptoms over 8 years (total effect 0.014; 95% CI 0.007-0.021), with C-reactive protein mediating 20.1% of this effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: